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Abstract
Case summary A 6-year-old female neutered domestic shorthair cat from Cyprus was presented with multiple 
ulcerated skin nodules. Cytology and histopathology of the lesions revealed granulomatous dermatitis with 
intracytoplasmic organisms, consistent with amastigotes of Leishmania species. Biochemistry identified a mild 
hyperproteinaemia. Blood extraction and PCR detected Leishmania species, Hepatozoon species and ‘Candidatus 
Mycoplasma haemominutum’ (CMhm) DNA. Subsequent sequencing identified Hepatozoon felis. Additionally, the 
rRNA internal transcribed spacer 1 locus of Leishmania infantum was partially sequenced and phylogeny showed 
it to cluster with species derived from dogs in Italy and Uzbekistan, and a human in France. Allopurinol treatment 
was administered for 6 months. Clinical signs resolved in the second month of treatment with no deterioration 8 
months post-treatment cessation. Quantitative PCR and ELISA were used to monitor L infantum blood DNA and 
antibody levels. The cat had high L infantum DNA levels pretreatment that gradually declined during treatment 
but increased 8 months post-treatment cessation. Similarly, ELISA revealed high levels of antibodies pretreatment, 
which gradually declined during treatment and increased slightly 8 months post-treatment cessation. The cat 
remained PCR positive for CMhm and Hepatozoon species throughout the study. There was no clinical evidence of 
relapse 24 months post-treatment.
Relevance and novel information To our knowledge, this is the first clinical report of a cat with leishmaniosis with 
H felis and CMhm coinfections. The high L infantum DNA levels post-treatment cessation might indicate that 
although the lesions had resolved, prolonged or an alternative treatment could have been considered.
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Introduction
Leishmania infantum, the causative agent of canine leish-
maniosis in Europe and a zoonotic vector-borne patho-
gen, has been increasingly reported in cats in the 
Mediterranean basin, providing mounting evidence that 
cats may act as a secondary reservoir.1 Experimental and 
case-control studies on feline leishmaniosis (FeL) are 
lacking, limiting our knowledge of this disease; thus epi-
demiological studies, case series and case descriptions 
are required to establish a better understanding of the 
clinicopathological presentations, treatment, monitoring 
and prevention of FeL.2
Herein, we describe the clinical, laboratory and molec-
ular findings, as well as treatment and prolonged moni-
toring data, from an adult domestic shorthair cat from 
Cyprus diagnosed with leishmaniosis caused by 
Leishmania infantum and coinfections with Hepatozoon 
felis and ‘Candidatus Mycoplasma haemominutum’ 
(CMhm).
Case description
A 6-year-old female neutered domestic shorthair cat was 
presented at the end of September 2014 to Cyvets 
Veterinary Centre, Paphos, Cyprus, owing to multiple 
ulcerated skin nodules on the forelimbs noted by the 
owner 1 day before presentation when the cat had 
returned having been missing for 2 weeks. The cat lived 
mainly outdoors in a rural area, had no travel history, 
was fully vaccinated and had occasional fipronil spot-on 
(Effipro; Virbac) ectoparasiticide application.
At presentation, the cat’s body condition score was 
5/9 and the only abnormalities detected were three 
round, ulcerated skin nodules; two of them were on the 
dorsal aspect of each forelimb, above the carpus (Figure 
1a) and the third was on the left scapula (Figure 1b). 
Owing to a recent diagnosis of cutaneous leprosy in a 
different cat from the same household, the lesion from 
the scapula was surgically excised for histopathological 
examination and imprint smears from one of the 
forelimb lesions were made for cytological examination. 
The latter revealed high numbers of macrophages, with 
an epithelioid appearance and occasional giant multinu-
cleated macrophages, as well as low numbers of plasma 
cells and small lymphocytes. Numerous organisms con-
sistent with Leishmania species amastigotes were noted 
in parasitophorous vacuoles of the macrophages and 
freely in the background (Figure 2a). Histopathological 
examination of the lesion (Figure 2b) revealed mild acan-
thosis and focal ulceration of the epidermis. Within the 
subjacent dermis, extending from the denuded surface 
to the deep dermis/panniculus, was an irregular, densely 
cellular area composed of macrophages, with low num-
bers of multinucleated forms. The macrophages con-
tained numerous intracytoplasmic vacuoles (5–7 μm in 
diameter) within which were densely amphophilic 
round-to-oval organisms (approximately 1 μm diame-
ter). The macrophages were mostly in random array; 
rarely groups of the cells were aggregated to form small 
granulomas. There were lighter admixtures of neutro-
phils, lymphocytes and plasma cells. The cytological and 
histopathological diagnosis was granulomatous derma-
titis with intralesional intracytoplasmic amastigotes con-
sistent with Leishmania species.
Blood samples were collected into EDTA and heparin 
and analysed by an automated haematology impedance 
analyser (Vet ABC; Scil) and by a VetScan VS2 chemistry 
analyser (Abaxis), respectively. Only mild hyperpro-
teinaemia (84.0 g/l; reference interval 54–82 g/l) was 
present. Blood smear examination and urine analysis 
were unremarkable.
The cat was also enrolled into an epidemiology study,3 
thus surplus EDTA-blood and plasma available were 
submitted for testing for the presence of infectious, 
including vector-borne, organisms. The cat was PCR 
positive for Hepatozoon species using conventional PCR, 
as well as positive for Leishmania species and CMhm 
using quantitative PCR (qPCR). Subsequent sequencing 
identified H felis and L infantum.3 Owing to the small size 
Figure 1 Ulcerated cutaneous skin nodules on the (a) left forelimb and (b) left scapula, month 0
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of the amplicon generated by the initial Leishmania spe-
cies PCR4 an additional PCR was performed, targeting 
the rRNA ITS1 locus of L infantum,5 followed by sequenc-
ing. The forward and reverse sequences of the L infantum 
were assembled and constructed into a consensus 
sequence, which was deposited in the GenBank database 
(MF140257). The DNA sequence was 100% identical to a 
partial 18S rRNA ITS1 sequence of L infantum (GenBank 
KX664454) over 258 bp, as found by BLAST analysis 
(http://www.ncbi.nlm.nih.gov/BLAST). Phylogeny 
(Figure 3) showed the L infantum from this Cypriot cat to 
cluster with species derived from dogs in Italy and 
Uzbekistan, a sandfly in Iran and a human in France. 
The cat was PCR negative for Mycoplasma haemofelis, 
‘Candidatus Mycoplasma turicensis’ (CMt), Bartonella 
henselae and Ehrlichia/Anaplasma species, and seronega-
tive for feline leukaemia virus antigen and feline immu-
nodeficiency virus antibodies.
Treatment with allopurinol at 10 mg/kg PO q12h was 
started (month 0) and administered for 6 months. The cat 
was examined every 2 months during treatment and 
then 8 months post-treatment cessation (month 14), with 
blood samples collected each time for haematology and 
biochemistry analysis. An ELISA was used to monitor L 
infantum-specific antibodies in serum,6 as well as qPCR4 
for calculating the L infantum DNA levels in the blood as 
previously described (Table 1).7 The L infantum DNA 
level of the surgically excised skin nodule was high 
(approximately 3.48 × 1010 relative copy numbers). 
Additionally, PCR assays were repeated for CMhm and 
Hepatozoon species.
The clinical signs gradually improved by month 1 
(Figure 4a) and resolved by month 2, with no clinical 
relapses evident at the completion of treatment (Figure 4b) 
nor up until the end of the follow-up period at month 14.
The cat had high L infantum DNA and antibody levels 
pretreatment at month 0. This DNA level had decreased 
by approximately 40-fold at month 2, and by approxi-
mately 5000-fold at month 6, compared with month 0. At 
month 14 the L infantum DNA level had approximately a 
500-fold increase compared with month 6. The L infantum 
antibodies showed a more subtle gradual decrease, reach-
ing a nadir at month 4, with approximately a three-fold 
decrease compared with month 0. From months 6 – 14 the 
antibodies remained at similar levels with approximately 
a two-fold elevation compared with the levels at month 4.
The cat remained PCR positive for CMhm and 
Hepatozoon species throughout the study and apart from 
the initial hyperproteinaemia, which resolved during 
month 2, no other haematological or biochemical abnor-
malities were detected. At month 30, while no PCR was 
performed, the cat remained clinically healthy with no 
evidence of clinical signs or relapse.
Discussion
The first case of FeL was reported in 1912 in Algeria,8 
and it was not until the past two decades that case 
reports and epidemiological studies established a 
description of clinical FeL including skin or mucocutane-
ous lesions and lymphadenomegaly.1 In contrast, fewer 
data are available regarding the treatment, monitoring 
and prognosis of FeL.
The LeishVet Group1 and the Advisory Board on Cat 
Diseases Guidelines9 both recommend allopurinol treat-
ment (10–20 mg/kg q24h or q12h) for FeL, based on the 
extensive clinical use of this medication in previous 
cases. In contrast, meglumine antimoniate has only 
been described in a few cases of FeL.10,11 Additionally, a 
combination of allopurinol and N-methyl-glucamine 
antimoniate in a cat with FeL due to L infantum was 
Figure 2 (a) Imprint smears from an ulcerated skin nodule revealed multinucleated macrophages (large arrow) with numerous 
intracellular organisms consistent with Leishmania species amastigotes (small arrows). Diff-Quik stain, scale bar = 10 μm. 
(b) Histopathological examination of a section of the nodule removed from the left scapula showed marked granulomatous 
dermatitis with intracytoplasmic organisms consistent with Leishmania species amastigotes in the macrophages (arrows). 
Haematoxylin and eosin stain, scale bar = 50 μm
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reported to have led to successful clinical resolution and 
significant reduction of the parasitic load, suggesting 
that this therapeutic protocol could also be considered 
for FeL.12
The cat in this case had complete clinical resolution 
of the cutaneous lesions during the treatment period 
with no relapse by month 24 after completion of the 6 
months of allopurinol treatment. However, the PCR 
results post-treatment showed that elimination of L 
infantum had not occurred, indicating progressive sub-
clinical infection. Given the potential role of the cat as a 
secondary reservoir and the zoonotic nature of L infan-
tum, an alternative treatment could have been imple-
mented for this patient, such as a combination of 
allopurinol with meglumine antimoniate or N-methyl-
glucamine antimoniate.
There are only a few case reports that provided pro-
longed follow-up for FeL,12–15 and only in one case did 
this comprise measurement of L infantum DNA levels and 
serology.12 In the current case, while the ELISA results fol-
lowed a similar pattern to the DNA levels during treat-
ment, they both failed to do the same during the 
monitoring period, in which the clinical signs resolved 
but parasitaemia persisted (Table 1). Persichetti et  al 
reported in a recent study that although ELISA serology 
was better for diagnosing clinical FeL compared with the 
immunofluorescent antibody test (IFAT), the latter was 
more sensitive than ELISA to detect subclinical infec-
tion.16 The same study also recommended Western blot 
as the preferable serological test for FeL since it yielded a 
higher sensitivity and specificity in comparison to ELISA 
and IFAT.
Table 1 Serological and PCR results of Leishmania infantum in a cat with clinical leishmaniosis and coinfections with 
Hepatozoon felis and ‘Candidatus Mycoplasma haemominutum’ during and after treatment with allopurinol at 10 mg/kg 
PO q12h for 6 months, which was started at month 0
Leishmania infantum Month 0
(pretreatment)
Month 2
(clinical resolution  
of lesions)
Month 4 Month 6
(treatment 
cessation)
Month 14
(8 months 
post-treatment 
cessation)
DNA level per PCR assay  
(relative copy numbers)
663,600 17,300 500 130 64,600
ELISA units (EU), cut off point for 
negative result is 9.2 EU
163 124 57 99 107
Figure 3 Maximum likelihood phylogenetic tree of Leishmania genera, based on rRNA ITS1 locus sequences and showing the 
position of the sequence derived from the Leishmania species found in the blood in the Cypriot cat (sample C174) with clinical 
leishmaniosis described in this report (MF140257). Species and strains are listed, followed by their GenBank accession numbers
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The pathogens infecting this cat were recently found 
to have a PCR prevalence of 3.1% for L infantum, 58.0% 
for Hepatozoon species and 33.0% for CMhm in non-
healthy Cypriot cats,3 with L infantum and Hepatozoon 
canis also being reported in the canine population of this 
island.17 Significant associations between L infantum 
infection and H felis and CMt infections in cats using mul-
tivariable logistic regression have been reported, suggest-
ing impaired host immune response due to the multiple 
coinfections.3 This could have been a component leading 
to the persistent L infantum parasitaemia in this cat in the 
face of the Hepatozoon species and CMhm coinfections.
Conclusions
To the best of our knowledge, this is the first clinical 
report of FeL caused by L infantum, with H felis and 
CMhm coinfection. While allopurinol treatment led to a 
complete resolution of the clinical signs, it failed to elimi-
nate the parasite, leading to persistent L infantum sub-
clinical infection. Thus, more aggressive treatment could 
be considered in future cases, potentially with the com-
bination of allopurinol with meglumine antimoniate or 
N-methyl-glucamine antimoniate, in order to achieve a 
more efficient control of L infantum.
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